Intratumoral Enterobacter hormaechei drives gemcitabine resistance in pancreatic cancer via cdd_L-mediated drug inactivation

References

[1] Siegel, Rebecca L., Angela N. Giaquinto, and Ahmedin Jemal. 2024. “Cancer Statistics, 2024.” CA: A Cancer Journal for Clinicians 74: 12–49. https://doi.org/10.3322/caac.21820

[2] de Laat, Vincent, Halit Topal, Xander Spotbeen, Ali Talebi, Jonas Dehairs, Jakub Idkowiak, Frank Vanderhoydonc, et al. 2024. “Intrinsic Temperature Increase Drives Lipid Metabolism Towards Ferroptosis Evasion and Chemotherapy Resistance in Pancreatic Cancer.” Nature Communications 15: 8540. https://doi.org/10.1038/s41467-024-52978-z

[3] Ku, Bomin, David Eisenbarth, Seonguk Baek, Tae-Keun Jeong, Ju-Gyeong Kang, Daehee Hwang, Myung-Giun Noh, et al. 2024. “PRMT1 Promotes Pancreatic Cancer Development and Resistance to Chemotherapy.” Cell Reports Medicine 5: 101461. https://doi.org/10.1016/j.xcrm.2024.101461

[4] Tsilimigras, Matthew C. B., Anthony Fodor, and Christian Jobin. 2017. “Carcinogenesis and Therapeutics: The Microbiota Perspective.” Nature Microbiology 2: 17008. https://doi.org/10.1038/nmicrobiol.2017.8

[5] Fu, Aikun, Bingqing Yao, Tingting Dong, Yongyi Chen, Jia Yao, Yu Liu, Hang Li, et al. 2022. “Tumor-Resident Intracellular Microbiota Promotes Metastatic Colonization in Breast Cancer.” Cell 185: 1356–72.e26. https://doi.org/10.1016/j.cell.2022.02.027

[6] Aykut, Berk, Smruti Pushalkar, Ruonan Chen, Qianhao Li, Raquel Abengozar, Jacqueline I. Kim, Sorin A. Shadaloey, et al. 2019. “The Fungal Mycobiome Promotes Pancreatic Oncogenesis Via Activation of MBL.” Nature 574: 264–7. https://doi.org/10.1038/s41586-019-1608-2

[7] McAllister, Florencia, Md Abdul Wadud Khan, Beth Helmink, and Jennifer A. Wargo. 2019. “The Tumor Microbiome in Pancreatic Cancer: Bacteria and Beyond.” Cancer Cell 36: 577–9. https://doi.org/10.1016/j.ccell.2019.11.004

[8] Jiang, Mingjie, Zhongyuan Yang, Juanjuan Dai, Tong Wu, Zan Jiao, Yongchao Yu, Kang Ning, Weichao Chen, and Ankui Yang. 2023. “Intratumor Microbiome: Selective Colonization in the Tumor Microenvironment and a Vital Regulator of Tumor Biology.” MedComm 4: e376. https://doi.org/10.1002/mco2.376

[9] Lehouritis, Panos, Joanne Cummins, Michael Stanton, Carola T. Murphy, Florence O. McCarthy, Gregor Reid, Camilla Urbaniak, William L. Byrne, and Mark Tangney. 2015. “Local Bacteria Affect the Efficacy of Chemotherapeutic Drugs.” Scientific Reports 5: 14554. https://doi.org/10.1038/srep14554

[10] Geller, Leore T., Michal Barzily-Rokni, Tal Danino, Oliver H. Jonas, Noam Shental, Deborah Nejman, Nancy Gavert, et al. 2017. “Potential Role of Intratumor Bacteria in Mediating Tumor Resistance to the Chemotherapeutic Drug Gemcitabine.” Science 357: 1156–60. https://doi.org/10.1126/science.aah5043

[11] Yeh, Ting-Kuang, Hsueh-Ju Lin, Po-Yu Liu, Jui-Hsing Wang, and Po-Ren Hsueh. 2022. “Antibiotic Resistance in Enterobacter Hormaechei.” International Journal of Antimicrobial Agents 60: 106650. https://doi.org/10.1016/j.ijantimicag.2022.106650

[12] Zhou, Kai, Yanzi Zhou, Chun-Xu Xue, Tingting Xu, Yunbo Chen, Ping Shen, and Yonghong Xiao. 2023. “Bloodstream Infections Caused By Enterobacter Hormaechei ST133 in China, 2010–22.” The Lancet. Microbe 4: e13. https://doi.org/10.1016/S2666-5247(22)00226-9

[13] Roberts, Leah W., Patrick N. A. Harris, Brian M. Forde, Nouri L. Ben Zakour, Elizabeth Catchpoole, Mitchell Stanton-Cook, Minh-Duy Phan, et al. 2020. “Integrating Multiple Genomic Technologies to Investigate an Outbreak of Carbapenemase-Producing Enterobacter Hormaechei.” Nature Communications 11: 466. https://doi.org/10.1038/s41467-019-14139-5

[14] Vande Voorde, Johan, Suna Sabuncuoğlu, Sam Noppen, Anders Hofer, Farahnaz Ranjbarian, Steffen Fieuws, Jan Balzarini, and Sandra Liekens. 2014. “Nucleoside-Catabolizing Enzymes in Mycoplasma-Infected Tumor Cell Cultures Compromise the Cytostatic Activity of the Anticancer Drug Gemcitabine.” Journal of Biological Chemistry 289: 13054–65. https://doi.org/10.1074/jbc.M114.558924

[15] Xu, Geng, Yaling Jiang, Chen Sun, Bernd W. Brandt, Kamran Nazmi, Luca Morelli, Giulia Lencioni, Elisa Giovannetti, and Dongmei Deng. 2025. “Role of Oral Bacteria in Mediating Gemcitabine Resistance in Pancreatic Cancer.” Biomolecules 15(7): 1018. https://doi.org/10.3390/biom15071018

[16] Geller, Leore T., and Ravid Straussman. 2018. “Intratumoral Bacteria May Elicit Chemoresistance by Metabolizing Anticancer Agents.” Molecular & Cellular Oncology 5: e1405139. https://doi.org/10.1080/23723556.2017.1405139

[17] Jiang, Lin, Lingxiao Zhang, Yijun Shu, Yuhan Zhang, Lili Gao, Shimei Qiu, Wenhua Zhang, et al. 2024. “Deciphering the Role of Enterococcus Faecium Cytidine Deaminase in Gemcitabine Resistance of Gallbladder Cancer.” Journal of Biological Chemistry 300: 107171. https://doi.org/10.1016/j.jbc.2024.107171

RIGHTS & PERMISSIONS

2026 The Author(s). iMeta published by John Wiley & Sons Australia, Ltd on behalf of iMeta Science.